Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 5828959, 9 pages
http://dx.doi.org/10.1155/2016/5828959
Review Article

Lower Level of Bacteroides in the Gut Microbiota Is Associated with Inflammatory Bowel Disease: A Meta-Analysis

Guangdong Province Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Guangzhou, China

Received 17 May 2016; Accepted 9 August 2016

Academic Editor: Yutao Yan

Copyright © 2016 Yingting Zhou and Fachao Zhi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. T. Osterman, R. Kundu, G. R. Lichtenstein, and J. D. Lewis, “Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis,” Gastroenterology, vol. 130, no. 4, pp. 1047–1053, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Srinivasan and A. K. Akobeng, “Thalidomide and thalidomide analogues for induction of remission in Crohn's disease,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD007350, 2009. View at Google Scholar · View at Scopus
  3. C. J. Damman, S. I. Miller, C. M. Surawicz, and T. L. Zisman, “The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation,” The American Journal of Gastroenterology, vol. 107, no. 10, pp. 1452–1459, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. P. B. Eckburg, E. M. Bik, C. N. Bernstein et al., “Microbiology: diversity of the human intestinal microbial flora,” Science, vol. 308, no. 5728, pp. 1635–1638, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. R. E. Ley, C. A. Lozupone, M. Hamady, R. Knight, and J. I. Gordon, “Worlds within worlds: evolution of the vertebrate gut microbiota,” Nature Reviews Microbiology, vol. 6, no. 10, pp. 776–788, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Houston, G. W. Blakely, A. McDowell, L. Martin, and S. Patrick, “Binding and degradation of fibrinogen by Bacteroides fragilis and characterization of a 54 kDa fibrinogen-binding protein,” Microbiology, vol. 156, no. 8, pp. 2516–2526, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. L. Round, S. M. Lee, J. Li et al., “The toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota,” Science, vol. 332, no. 6032, pp. 974–977, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, “Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement,” International Journal of Surgery, vol. 8, no. 5, pp. 336–341, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. D. F. Stroup, J. A. Berlin, S. C. Morton et al., “Meta-analysis of observational studies in epidemiology: a proposal for reporting,” Journal of the American Medical Association, vol. 283, no. 15, pp. 2008–2012, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Brito, C. Zaltman, A. T. P. Carvalho et al., “Subgingival microflora in inflammatory bowel disease patients with untreated periodontitis,” European Journal of Gastroenterology and Hepatology, vol. 25, no. 2, pp. 239–245, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. M. P. Conte, S. Schippa, I. Zamboni et al., “Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease,” Gut, vol. 55, no. 12, pp. 1760–1767, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Mylonaki, N. B. Rayment, D. S. Rampton, B. N. Hudspith, and J. Brostoff, “Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 11, no. 5, pp. 481–487, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. F. C. Nwosu, L.-T. Thorkildsen, E. Avershina et al., “Age-dependent fecal bacterial correlation to inflammatory bowel disease for newly diagnosed untreated children,” Gastroenterology Research and Practice, vol. 2013, Article ID 302398, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. K.-L. Kolho, K. Korpela, T. Jaakkola et al., “Fecal microbiota in pediatric inflammatory bowel disease and its relation to inflammation,” American Journal of Gastroenterology, vol. 110, no. 6, pp. 921–930, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Andoh, H. Kuzuoka, T. Tsujikawa et al., “Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease,” Journal of Gastroenterology, vol. 47, no. 12, pp. 1298–1307, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Ashorn, T. Honkanen, K.-L. Kolho et al., “Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 15, no. 2, pp. 199–205, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Basset, J. Holton, A. Bazeos, D. Vaira, and S. Bloom, “Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease?” Digestive Diseases and Sciences, vol. 49, no. 9, pp. 1425–1432, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Kleessen, A. J. Kroesen, H. J. Buhr, and M. Blaut, “Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls,” Scandinavian Journal of Gastroenterology, vol. 37, no. 9, pp. 1034–1041, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Sokol, P. Seksik, L. Rigottier-Gois et al., “Specificities of the fecal microbiota in inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 12, no. 2, pp. 106–111, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Swidsinski, A. Ladhoff, A. Pernthaler et al., “Mucosal flora in inflammatory bowel disease,” Gastroenterology, vol. 122, no. 1, pp. 44–54, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Swidsinski, J. Weber, V. Loening-Baucke, L. P. Hale, and H. Lochs, “Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease,” Journal of Clinical Microbiology, vol. 43, no. 7, pp. 3380–3389, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Takaishi, T. Matsuki, A. Nakazawa et al., “Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease,” International Journal of Medical Microbiology, vol. 298, no. 5-6, pp. 463–472, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Andoh, H. Imaeda, T. Aomatsu et al., “Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis,” Journal of Gastroenterology, vol. 46, no. 4, pp. 479–486, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. R. K. Linskens, X. W. Huijsdens, P. H. M. Savelkoul, C. M. J. E. Vandenbrouckc-Grauls, and S. G. M. Meuwissen, “The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics,” Scandinavian Journal of Gastroenterology. Supplement, vol. 36, no. 234, pp. 29–40, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Desreumaux and J.-F. Colombel, “Intestinal flora and Crohn's disease,” Annales Pharmaceutiques Francaises, vol. 61, no. 4, pp. 276–281, 2003. View at Google Scholar · View at Scopus
  26. A. Schwiertz, M. Jacobi, J.-S. Frick, M. Richter, K. Rusch, and H. Köhler, “Microbiota in pediatric inflammatory bowel disease,” The Journal of Pediatrics, vol. 157, no. 2, pp. 240–244.e1, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Matsumoto, N. Watanabe, A. Imaoka, and Y. Okabe, “Preventive effects of Bifidobacterium- and Lactobacillus-fermented milk on the development of inflammatory bowel disease in senescence-accelerated mouse P1/Yit strain mice,” Digestion, vol. 64, no. 2, pp. 92–99, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Swidsinski, V. Loening-Baucke, and A. Herber, “Mucosal flora in Crohn's disease and ulcerative colitis—an overview,” Journal of Physiology and Pharmacology, vol. 60, supplement 6, pp. 61–71, 2009. View at Google Scholar · View at Scopus